Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer
- 1 February 2000
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 26 (1) , 53-65
- https://doi.org/10.1053/ctrv.1999.0150
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- Prognostic value of bone marrow biopsy in operable breast cancer patients at the time of initial diagnosis: Results of a 20-year median follow-upBreast Cancer Research and Treatment, 1998
- Prognostische Bedeutung des Tumorzellnachweises im Knochenmark im Vergleich zum Nodalstatus beim primären MammakarzinomGeburtshilfe und Frauenheilkunde, 1997
- Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastasesThe Lancet, 1996
- Bone marrow micrometastases in primary breast cancer: Prognostic significance after 6 years' follow-upEuropean Journal of Cancer and Clinical Oncology, 1991
- DETECTION OF MICROMETASTASES IN PATIENTS WITH PRIMARY BREAST CANCERThe Lancet, 1983
- Prognostic value of bone marrow biopsy in breast cancerCancer, 1982
- Increased detection of mammary carcinoma cells in marrow smears using antisera to epithelial membrane antigenBritish Journal of Cancer, 1981
- Distribution of epithelial membrane antigen in normal and neoplastic tissues and its value in diagnostic tumor pathologyCancer, 1981
- The use of antisera to epithelial membrane antigen in detecting micrometastases in histological sectionsBritish Journal of Cancer, 1980
- The bone marrow examination in breast cancer.Diagnostic considerations and clinical usefulnessCancer, 1978